Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. N-(4-methoxy-1,2,5-thiadiazol-3-yl)sulfanilamide
2. St 8005
3. Sulfametrol
1. 32909-92-5
2. Sulfametrol
3. Sulfametrolum
4. 4-amino-n-(4-methoxy-1,2,5-thiadiazol-3-yl)benzenesulfonamide
5. F5ak41ipqg
6. N1-(4-methoxy-1,2,5-thiadiazol-3-yl)sulfanilamide
7. Sulfametrole (inn)
8. Sulfametrole [inn]
9. 4-amino-n-(4-methoxy-1,2,5-thiadiazol-3-yl)benzene-1-sulfonamide
10. Unii-f5ak41ipqg
11. Sulfametrole [inn:ban]
12. Sulfametrol [inn-spanish]
13. Sulfametrolum [inn-latin]
14. Lidaprim (tn)
15. Einecs 251-288-1
16. Sulfametrole [mi]
17. Sulfametrole [mart.]
18. Schembl148552
19. Sulfametrole [who-dd]
20. Chembl2105398
21. Chebi:88258
22. Gtpl12702
23. Dtxsid40865655
24. Izoymgqqvnamhs-uhfffaoysa-n
25. 4-amino-n-(5-methoxy-2,1,3-thiadiazol-4-yl)benzolsulfonamid
26. Hy-133937
27. Cs-0135813
28. Ft-0727929
29. Ns00004247
30. D08541
31. Q7636179
32. N1-(4-methoxy-1,2,5-thiadiazol-3-yl)-sulfanilamide
33. N(sup 1)-(4-methoxy-1,2,5-thiadiazol-3-yl)sulfanilamide
34. 3-methoxy-4-(4'-aminobenzene-sulfonamido)-1,2,5-thiadiazole
35. 3-methoxy-4-(4'-aminobenzenesulfonamido)-1,2,5-thiadiazole
36. Benzenesulfonamide, 4-amino-n-(4-methoxy-1,2,5-thiadiazol-3-yl)-; Sulfanilamide, N1-(4-methoxy-1,2,5-thiadiazol-3-yl)- (7ci,8ci); 1,2,5-thiadiazole, Benzenesulfonamide Deriv.; 4-amino-n-(4-methoxy-1,2,5-thiadiazol-3-yl)benzenesulfonamide; Sulfametrole
Molecular Weight | 286.3 g/mol |
---|---|
Molecular Formula | C9H10N4O3S2 |
XLogP3 | 0.8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 4 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 144 |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 365 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
48
PharmaCompass offers a list of Sulfametrole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sulfametrole manufacturer or Sulfametrole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sulfametrole manufacturer or Sulfametrole supplier.
PharmaCompass also assists you with knowing the Sulfametrole API Price utilized in the formulation of products. Sulfametrole API Price is not always fixed or binding as the Sulfametrole Price is obtained through a variety of data sources. The Sulfametrole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lidaprim (TN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lidaprim (TN), including repackagers and relabelers. The FDA regulates Lidaprim (TN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lidaprim (TN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lidaprim (TN) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lidaprim (TN) supplier is an individual or a company that provides Lidaprim (TN) active pharmaceutical ingredient (API) or Lidaprim (TN) finished formulations upon request. The Lidaprim (TN) suppliers may include Lidaprim (TN) API manufacturers, exporters, distributors and traders.
click here to find a list of Lidaprim (TN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lidaprim (TN) written confirmation (Lidaprim (TN) WC) is an official document issued by a regulatory agency to a Lidaprim (TN) manufacturer, verifying that the manufacturing facility of a Lidaprim (TN) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lidaprim (TN) APIs or Lidaprim (TN) finished pharmaceutical products to another nation, regulatory agencies frequently require a Lidaprim (TN) WC (written confirmation) as part of the regulatory process.
click here to find a list of Lidaprim (TN) suppliers with Written Confirmation (WC) on PharmaCompass.
Lidaprim (TN) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lidaprim (TN) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lidaprim (TN) GMP manufacturer or Lidaprim (TN) GMP API supplier for your needs.
A Lidaprim (TN) CoA (Certificate of Analysis) is a formal document that attests to Lidaprim (TN)'s compliance with Lidaprim (TN) specifications and serves as a tool for batch-level quality control.
Lidaprim (TN) CoA mostly includes findings from lab analyses of a specific batch. For each Lidaprim (TN) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lidaprim (TN) may be tested according to a variety of international standards, such as European Pharmacopoeia (Lidaprim (TN) EP), Lidaprim (TN) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lidaprim (TN) USP).